Proposed Rule2025-11271
Petition for Rulemaking of Alliance for Natural Health USA; Xlear, Inc.; and Better Way Health
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 18, 2025
Issuing agencies
Federal Trade Commission
Abstract
Please take notice that the Federal Trade Commission ("Commission") received a petition for rulemaking from Alliance for Natural Health USA; Xlear, Inc.; and Better Way Health, and has published that petition online at https://www.regulations.gov. The Commission invites written comments concerning the petition. Publication of this petition is pursuant to the Commission's Rules of Practice and Procedure and does not affect the legal status of the petition or its final disposition.
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 116 (Wednesday, June 18, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 116 (Wednesday, June 18, 2025)]
[Proposed Rules]
[Page 25918]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-11271]
=======================================================================
-----------------------------------------------------------------------
FEDERAL TRADE COMMISSION
16 CFR Parts 2 and 3
[File No. R507004]
Petition for Rulemaking of Alliance for Natural Health USA;
Xlear, Inc.; and Better Way Health
AGENCY: Federal Trade Commission.
ACTION: Receipt of petition; request for comment.
-----------------------------------------------------------------------
SUMMARY: Please take notice that the Federal Trade Commission
(``Commission'') received a petition for rulemaking from Alliance for
Natural Health USA; Xlear, Inc.; and Better Way Health, and has
published that petition online at <a href="https://www.regulations.gov">https://www.regulations.gov</a>. The
Commission invites written comments concerning the petition.
Publication of this petition is pursuant to the Commission's Rules of
Practice and Procedure and does not affect the legal status of the
petition or its final disposition.
DATES: Comments must identify the petition docket number and be filed
by July 18, 2025.
ADDRESSES: You may view the petition, identified by docket number FTC-
2025-0036, and submit written comments concerning its merits by using
the Federal eRulemaking Portal at <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Follow
the online instructions for submitting comments. Do not submit
sensitive or confidential information. You may read background
documents or comments received at <a href="https://www.regulations.gov">https://www.regulations.gov</a> at any
time.
FOR FURTHER INFORMATION CONTACT: Office of the Secretary (phone: 202-
326-2514, email: <a href="/cdn-cgi/l/email-protection#3d7851585e494f5253545e7b545154535a4e7d5b495e135a524b"><span class="__cf_email__" data-cfemail="9fdaf3fafcebedf0f1f6fcd9f6f3f6f1f8ecdff9ebfcb1f8f0e9">[email protected]</span></a>), Federal Trade Commission,
600 Pennsylvania Avenue NW, Washington, DC 20580.
SUPPLEMENTARY INFORMATION: Pursuant to section 18(a)(1)(B) of the
Federal Trade Commission Act, 15 U.S.C. 57a(1)(B), and FTC Rule
1.31(f), 16 CFR 1.31(f), notice is hereby given that the above-
captioned petition has been filed with the Secretary of the Commission
and has been placed on the public record for a period of 30 days. Any
person may submit comments in support of or in opposition to the
petition. All timely and responsive comments submitted in connection
with this petition will become part of the public record.
This petition requests to reform FTC procedures and practices
affecting the issuance of civil investigative demands; FTC burdens of
proof and pleading requirements in hearings; and FTC procedures and
practices affecting appeals from Initial Decisions of Administrative
Law Judges in health-related product advertising cases under Sections 5
and 12 of the Federal Trade Commission Act. The Commission will not
consider the petition's merits until after the comment period closes.
It may grant or deny the petition in whole or in part, and it may deem
the petition insufficient to warrant commencement of a rulemaking
proceeding. The purpose of this document is to facilitate public
comment on the petition to aid the Commission in determining what, if
any, action to take regarding the request contained in the petition.
This document is not intended to start, stop, cancel, or otherwise
affect rulemaking proceedings in any way.
Because your comment will be placed on the publicly accessible
website at <a href="https://www.regulations.gov">https://www.regulations.gov</a>, you are solely responsible for
making sure your comment does not include any sensitive or confidential
information. In particular, your comment should not include any
sensitive personal information, such as your or anyone else's Social
Security number; date of birth; driver's license number or other state
identification number, or foreign country equivalent; passport number;
financial account number; or credit or debit card number. You are also
solely responsible for making sure your comment does not include any
sensitive health information, such as medical records or other
individually identifiable health information. In addition, your comment
should not include any ``trade secret or any commercial or financial
information which . . . is privileged or confidential''--as provided by
section 6(f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2),
16 CFR 4.10(a)(2).
Authority: 15 U.S.C. 46; 15 U.S.C. 57a; 5 U.S.C. 601 note.
April J. Tabor,
Secretary.
[FR Doc. 2025-11271 Filed 6-17-25; 8:45 am]
BILLING CODE 6750-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 18, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.